Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

@article{Wang2020ClinicalCO,
  title={Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.},
  author={Dawei Wang and Bo Hu and Chang Hu and Fangfang Zhu and Xing Liu and Jing Zhang and Binbin Wang and Hui Xiang and Zhenshun Cheng and Yong Xiong and Yan Zhao and Yirong Li and Xinghuan Wang and Zhiyong Peng},
  journal={JAMA},
  year={2020}
}
Importance In December 2019, novel coronavirus (2019-nCoV)-infected pneumonia (NCIP) occurred in Wuhan, China. The number of cases has increased rapidly but information on the clinical characteristics of affected patients is limited. Objective To describe the epidemiological and clinical characteristics of NCIP. Design, Setting, and Participants Retrospective, single-center case series of the 138 consecutive hospitalized patients with confirmed NCIP at Zhongnan Hospital of Wuhan University… 

Figures and Tables from this paper

Epidemiological and Clinical Characteristics of 17 Hospitalized Patients with 2019 Novel Coronavirus Infections Outside Wuhan, China

Data from 17 confirmed cases of novel coronavirus pneumonia infected with 2019-nCoV in Dazhou provided some information that younger age, higher lymphocytes levels and monocytes levels at the diagnoses of 2019- nCoV may contributed to faster recovery and better therapeutic outcome.

Presenting Characteristics, Comorbidities, and Outcomes Among Hospitalized Patients with 2019 Novel Coronavirus-infected Pneumonia in Tehran, Iran

Hospitalized NCIP patients who have serious underlying chronic illness might be at higher risk for severe illness and what is the epidemiological, clinical, laboratory, radiological characteristics, and outcomes of the disease.

Clinical characteristics of 60 discharged cases of 2019 novel coronavirus-infected pneumonia in Taizhou, China

Early therapy and comprehensive therapy are key to the outcome for patients with COVID-19-infected pneumonia, especially for those with severe pneumonia.

Clinical Features and Treatment of 221 Patients with COVID-19 in Wuhan, China

55 severe patients with elder age and chronic comorbidities, developed more than one complication and the mortality rate was significantly higher in the severe patients compared to that in the non-severe patients, suggesting that the delayed use of corticosteroid might increase the risk of death in ICU.

Clinical characteristics of hospitalized patients with COVID-19 in Yueyang, Hunan, China

Severe cases were associated with older age or patients with comorbidities, secondary bacterial infections, and higher levels of C-reactive protein, and longer duration of virus clearance was associated with a higher risk of progression to critical status.

Clinical Characteristics of Patients with Severe Pneumonia Caused by the 2019 Novel Coronavirus in Wuhan, China

Clinicians should focus on advanced age, lymphocyte decline, and D-dimer elevation are important characteristics of patients with severe pneumonia to identify high-risk patients at an early stage of the disease.

Clinical course and outcome of novel coronavirus COVID-19 infection in 107 patients discharged from the Wuhan hospital

A period of 7–13 days after illness onset is the critical stage in COVID-19 progression, when severe cases showed persistent lymphopenia, severe acute respiratory dyspnea syndrome, refractory shock, anuric acute kidney injury, coagulopathy, thrombocytopenia and death.

Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing,China

The epidemiological and clinical characteristics of COVID-19 in non-Wuhan area are described, its effective treatment is explored, and the common clinical symptoms disappeared basically.

Clinical and Laboratory Profiles of 75 Hospitalized Patients with Novel Coronavirus Disease 2019 in Hefei, China

It is concluded that COVID-19 could cause different degrees of hematological abnormalities and damage of internal organs andAntiviral treatment requires a comprehensive and supportive approach.

Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study

In this case series in Jiangsu Province, COVID-19 patients had less severe symptoms and had better outcomes than the initial COVID theses in Wuhan, and the BMI ≥ 28 kg/m2 and a known history of type 2 diabetes were independent risk factors of severe illness in patients with CO VID-19.
...

References

SHOWING 1-10 OF 28 REFERENCES

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily, which is the seventh member of the family of coronaviruses that infect humans.

Clinical Time Features and Chest Imaging of 85 Patients With COVID-19 in Zhuhai, China

The incubation period of SARS-CoV-2 may be longer than 14 days; thus, medical surveillance after contact is required for longer than this.

Clinical Features, Diagnosis, and Treatment of COVID-19 in Hospitalized Patients: A Systematic Review of Case Reports and Case Series

Development of ARDS may play a role in estimating disease progression and mortality risk and early detection of elevations in serum CRP, combined with a clinical COVID-19 symptom presentation may be used as a surrogate marker for the presence and severity of the disease.

Coronavirus Disease 2019: A Comprehensive Review of Etiology, Pathogenesis, Diagnosis, and Ongoing Clinical Trials

The off-label use of drugs such as hydroxychloroquine and emergency use authorization of remdesivir can hopefully help the clinicians while treating critically ill patients and the use of convalescent serum has shown some interim benefit until a definitive treatment and preventive options are uncovered.

Clinical Characteristics and Reasons for Differences in Duration From Symptom Onset to Release From Quarantine Among Patients With COVID-19 in Liaocheng, China

The majority of COVID-19 cases in the study area were mild and moderate, with good clinical outcomes, and the reasons for differences in the duration from symptom onset to release from quarantine were complex.

Novel Insights Into Illness Progression and Risk Profiles for Mortality in Non-survivors of COVID-19

The data show that patients experienced consecutive changes in biochemical and immune parameters with the deterioration of the disease, indicating the necessity of early intervention.

Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle

A new-type coronav virus, tentatively named by World Health Organization as the 2019-new coronavirus (2019-nCoV), had caused this outbreak in Wuhan city, Hubei Province, China, it was announced today.

New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention

This review combines experimental and clinical evidence into a systematic analysis and summary of the current progress of research into SARS-CoV-2, from multiple perspectives, with the aim of gaining a better overall understanding of the disease.